Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab. Issue 1 (21st November 2018)

• Record Type: Journal Article
• Authors: Minami, Daisuke; Kayatani, Hiroe; Sato, Ken; Fujiwara, Keiichi; Shibayama, Takuo
• Is Part Of: Respirology case reports. Volume 7:Issue 1(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-11-21
• Subjects: Allergic -- asthma -- benralizumab -- eosinophilic -- omalizumab; Respiratory organs -- Diseases -- Periodicals; 616.2005
• DOI: 10.1002/rcr2.388
• Languages: English
• ISSNs: 2051-3380

Abstract

Abstract : A 64‐year‐old woman, who had presented with a 30‐year history of refractory asthma, and been treated with anti‐allergic drug therapy, inhaled corticosteroids, a long‐acting beta‐agonist, and a long‐acting muscarinic antagonist. She had been characterized as an allergic, eosinophilic asthmatic. Although omalizumab was tried initially, it was found to be insufficient. We began treatment with benralizumab. The asthma symptom control and sinusitis were improved immediately. Benralizumab was effective for overlapping patient population following negative initial results with omalizumab. Abstract : We present a patient with both allergic and eosinophilic predominant asthma whose asthma symptom control and sinusitis were improved by benralizumab following negative initial results with omalizumab.